Clobetasone butyrate
CAS No. 25122-57-0
Clobetasone butyrate ( —— )
产品货号. M24140 CAS No. 25122-57-0
丁酸氯倍他松可用于缓解皮质类固醇反应性皮肤病,包括特应性皮炎和牛皮癣。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥112 | 有现货 |
|
| 5MG | ¥163 | 有现货 |
|
| 10MG | ¥221 | 有现货 |
|
| 25MG | ¥346 | 有现货 |
|
| 50MG | ¥500 | 有现货 |
|
| 100MG | ¥708 | 有现货 |
|
| 500MG | ¥1737 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥250 | 有现货 |
|
生物学信息
-
产品名称Clobetasone butyrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述丁酸氯倍他松可用于缓解皮质类固醇反应性皮肤病,包括特应性皮炎和牛皮癣。
-
产品描述Clobetasone butyrate can be used to relieve corticosteroid-responsive dermatoses, including atopic?dermatitis and psoriasis. Clobetasone butyrate is a synthetic glucocorticoid. It has topical anti-inflammatory activity especially in skin .
-
体外实验——
-
体内实验Clobetasone butyrate (application on the skin; 0.05%; 7 weeks) induces epidermal thinning in skin, Clobetasone butyrate 7 weeks causes much less epidermal thinning in the pig than flurandrenolone (0.05%) or fluocinolone acetonide (0.025%), both of which causes severe atrophy. Animal Model:Large white domestic pigDosage:0.5% application on the skin Administration:7 weeks Result:Caused moderate to slight atrophy.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体glucocorticoid
-
研究领域——
-
适应症——
化学信息
-
CAS Number25122-57-0
-
分子量478.98
-
分子式C26H32ClFO5
-
纯度>98% (HPLC)
-
溶解度DMSO:240 mg/mL (501.06 mM)
-
SMILESC[C@@]1(C2)[C@](C(CCl)=O)(OC(CCC)=O)[C@@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)C2=O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Munro DD, et al. Clobetasone?butyrate, a?new?topical?corticosteroid:?clinical?activity?and?effects?on?pituitary-adrenal?axis?function?and?model?of?epidermal?atrophy.
产品手册
关联产品
-
Ranolazine
雷诺嗪是一种通过钠/钙通道的钙摄取抑制剂,用于治疗慢性心绞痛。
-
ONPG
ONPG 是一种比色和分光光度底物,用于检测 β-半乳糖苷酶活性。
-
pTH (64-84) (human)
pTH (64-84) (human)
021-51111890
购物车()
sales@molnova.cn

